GEMMs have shown how loss of tumour suppressor genes, such as Rb and Trp53, can influence immune evasion and the recruitment of immunosuppressive cells, providing insights into potential immunotherapeutic strategies [116]. The gene discussed is TP53; the disease is neoplasm.